Gap Coverage For Brand Drugs Urged In Draft Call Letter For 2008 Part D Plans
This article was originally published in The Pink Sheet Daily
Executive Summary
CMS’ Abby Block says the agency wants increased numbers of Part D plans offering preferred brands as well as generic coverage in the donut hole.
You may also be interested in...
CIGNA's Limited Brand Coverage In Part D Gap Emphasizes Challenges
After several years of no national Medicare Part D prescription drug plan sponsors offering any kind of brand drug coverage in the donut hole, CIGNA's "Medicare Rx Plan Three" product offering in 2010 will give seniors suffering from hypothyroidism that option
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.